{"SPADE_N_05855": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_N_05855", "Peptide Name": "Stigmurin", "Source": "Tityus stigmurus", "Family": "Derived from scorpion venom peptide", "Gene": "Not found", "Sequence": "FFSLIPSLVGGLISAFK", "Sequence Length": 17, "UniProt Entry": "No entry found", "Protein Existence": "Transcript level", "Biological Activity": ["Antimicrobial", "Antibacterial", "Anti-Gram+", "Antifungal", "Antiparasitic", "Antiproliferative"], "Target Organism": "[Ref.29670004] Gram-positive bacteria:Staphylococcus aureus ATCC 29213 (MIC=9.38 μM), Staphylococcus epidermidis ATCC 122225 (MIC=9.38 μM);yeasts:Candida albicans ATCC 90028 (MIC=37.5 μM);Stigmurin inhibit 90% of the epimastigote forms of Trypanosoma cruzi growth at 25 ?M;HeLa cell line:IC50=7.98 μM", "Hemolytic Activity": "[Ref.29670004]Hemolysis 0% at 1.17 μM, hemolysis 1% at 2.34 μM, hemolysis 1% at 4.69 μM, hemolysis 0% at 9.38 μM, hemolysis 1% at 18.75 μM, hemolysis 1% at 37.50 μM, hemolysis 3% at 75.00 μM against human red blood cell", "Cytotoxicity": "[Ref.29670004] The cell viability of HeLa cell lines is 56%, 66%, 66%, 81%, 78%, 66% and 30% at peptide concentrations of 2, 4, 8, 10, 15,  20 and 40 μM.The cell viability of 3T3 cell lines is 81%, 63%, 51%, 29%, 27%, 19% and 15% at peptide concentra", "Binding Target": "Not found", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Amidation", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C89H138N18O21", "Mass": 1796.16, "PI": 8.75, "Net Charge": 1, "Hydrophobicity": 1.54, "Half Life": "Mammalian:1.1 hourYeast:3 minE.coli:2 min", "Function": "Antibacterial activity against the Gram-positive bacteria. Antifungal activity against yeasts.Antiparasitic Activity against epimastigote forms of Trypanosoma cruzi. Antiproliferative Activity against HeLa cells.", "Literature": [{"Title": "Analogs of the Scorpion Venom Peptide Stigmurin Structural Assessment, Toxicity, and Increased Antimicrobial Activity.", "Pubmed ID": "29670004", "Reference": "Toxins (Basel). 2018 Apr 18;10(4). pii E161.", "Author": "Parente AMS, Daniele-Silva A, Furtado AA, Melo MA, Lacerda AF, Queiroz M, Moreno C, Santos E, Rocha HAO, Barbosa EG, Carvalho E, Silva-Júnior AA, Silva MS, Fernandes-Pedrosa MF.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=29670004"}], "Frequent Amino Acids": "FLS", "Absent Amino Acids": "CDEHMNOQRTUWY", "Basic Residues": 1, "Acidic Residues": 0, "Hydrophobic Residues": 11, "Polar Residues": 6, "Positive Residues": 1, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_11719", "Similarity": 0.8823529411764706, "Sequence": "FFSLIPKLVKGLISAFK"}, {"SPADE_ID": "SPADE_UN_24442", "Similarity": 0.8823529411764706, "Sequence": "FFSLIPKLVGKLISAFK"}, {"SPADE_ID": "SPADE_N_03227", "Similarity": 0.8823529411764706, "Sequence": "FLSLIPSLVGGSISAFK"}]}}}